People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and ...

The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...

Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning for anyone taking Ozempic, Wegovy, Rybelsus, or Mounjaro. The health body made the appeal on social media for anyone ...

It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, ...

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning for anyone taking Ozempic, Wegovy, Rybelsus, or Mounjaro ...

This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...

It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Leading global healthcare company Novo Nordisk announces the launch of Wegovy® in Hong Kong, now available at private clinics and selected pharmacies.